The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT

Molecular Endocrinology
T A JacksonK B Horwitz

Abstract

Steroid receptor antagonists, such as the antiestrogen tamoxifen or the antiprogestin RU486, can have inappropriate agonist-like effects in tissues and tumors. To explain this paradox we postulated that coactivators are inadvertently brought to the promoters of DNA-bound, antagonist-occupied receptors. The human (h) progesterone receptor (PR) hinge-hormone binding domain (H-HBD) was used as bait in a two-hybrid screen of a HeLa cDNA library, in which the yeast cells were treated with RU486. We have isolated and characterized two interesting steroid receptor-interacting proteins that regulate transcription in opposite directions. The first is L7/SPA, a previously described 27-kDa protein containing a basic region leucine zipper domain, having no known nuclear function. When coexpressed with tamoxifen-occupied estrogen receptors (hER) or RU486-occupied hPR or glucocorticoid receptors (hGR), L7/SPA increases the partial agonist activity of the antagonists by 3- to 10-fold, but it has no effect on agonist-mediated transcription. The interaction of L7/SPA with hPR maps to the hinge region, and indeed, the hPR hinge region squelches L7/SPA-dependent induction of antagonist-mediated transcription. Interestingly, pure antagonists that ...Continue Reading

Citations

Jan 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Anders StrömJan-Ake Gustafsson
Sep 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jonna FrasorBenita S Katzenellenbogen
Feb 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Sung Hee BaekMichael G Rosenfeld
Jun 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Zheng LiuBert W O'Malley
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·M M MontanoB S Katzenellenbogen
Jan 23, 1999·The Journal of Biological Chemistry·S H Hong, M L Privalsky
Nov 19, 2010·The Journal of Biological Chemistry·Haitao ZhangXu Shen
Feb 13, 2009·The Journal of Biological Chemistry·Hany Abdel-HafizKathryn B Horwitz
Nov 7, 2006·Nucleic Acids Research·Jorge Lopez-GarciaSimak Ali
Jan 5, 2000·Genes & Development·V PerissiM G Rosenfeld
Jul 25, 2012·Molecular and Cellular Biology·Khalid HilmiSylvie Mader
Aug 18, 2006·Molecular and Cellular Biology·Yin WuRyoichi Takayanagi
Jul 9, 2002·Molecular and Cellular Biology·Suzanne E WardellDean P Edwards
Sep 7, 2002·Molecular and Cellular Biology·Anna N MoraitisCatherine C Thompson
Oct 15, 2008·Molecular Cancer Therapeutics·Myles C HodgsonSteven P Balk
Nov 23, 2006·Reproductive Biology and Endocrinology : RB&E·Kristof ChwaliszWalter Elger
Jun 9, 2009·Endocrine Reviews·Evanthia Diamanti-KandarakisAndrea C Gore
Mar 11, 2006·Molecular Endocrinology·Sophie CarascossaStéphan Jalaguier
Jul 28, 1999·Environmental Health Perspectives·C WalkerJ Vandenbergh
Feb 16, 2006·Molecular and Cellular Biology·Ahmed ChadliDavid Toft
Jun 10, 2009·Breast Cancer Research and Treatment·Marc P J McCaffertyMichael J Kerin
Feb 26, 2000·European Journal of Biochemistry·L C TsaiT C Chang
Apr 1, 2009·Cellular and Molecular Life Sciences : CMLS·Stephan EllmannPamela L Strissel
May 14, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P ErolesA Lluch
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·B Sato
May 9, 2003·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Junichi Kurebayashi
May 9, 2003·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hirotaka Iwase
Feb 1, 2000·Trends in Endocrinology and Metabolism : TEM·X Hu, M A Lazar
Jun 8, 2002·Toxicology Letters·Patrick Diel
May 22, 2009·Expert Opinion on Therapeutic Targets·Melanie Spears, John Bartlett
Aug 31, 2006·Expert Opinion on Emerging Drugs·Attila MihalyiThomas M D'Hooghe
Oct 27, 2004·Expert Opinion on Investigational Drugs·Lucia PicarielloMaria Luisa Brandi
Oct 23, 2012·The Urologic Clinics of North America·Faris Azzouni, James Mohler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.